<DOC>
	<DOC>NCT00356395</DOC>
	<brief_summary>we hypothesized that combination therapy has additive beneficial effects to improve endothelial dysfunction and adipocytokine profiles in patients with hypertension.</brief_summary>
	<brief_title>Safety and Effects of Ramipril Combined With Candesartan</brief_title>
	<detailed_description>Forty patients will be given ramipril 10 mg and placebo, ramipril 10 mg and candesartan 16 mg, or candesartan 16 mg and placebo daily in a randomized, double-blind, placebo-controlled cross-over trial with three treatment arms and two washout periods (each 2 months).</detailed_description>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>patients with mild to moderate hypertension We will exclude patients with severe hypertension, unstable angina, acute myocardial infarction, or renal insufficiency.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>endothelial function, insulin resistance, adipocytokines</keyword>
</DOC>